Insider · CIK 0001999888
Peter Anastasiou
Files at HRMY (Harmony Biosciences Holdings, Inc.). First filing -, latest -.
In brief
Peter Anastasiou files SEC Form 4 as director and COO at HRMY (Harmony Biosciences Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Peter Anastasiou has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 2, 2026 | HRMY Harmony Biosciences Holdings, Inc. | AGrant or award Stock Optionderivative | +212,241 | $0.00 | $0 | 212,241 | Apr 6, 2026 |
| May 15, 2025 | HRMY Harmony Biosciences Holdings, Inc. | AGrant or award Stock Optionderivative | +14,522 | $0.00 | $0 | 14,522 | May 16, 2025 |
| Nov 5, 2023 | HRMY Harmony Biosciences Holdings, Inc. | AGrant or award Stock Optionderivative | +6,771 | $0.00 | $0 | 6,771 | Nov 8, 2023 |
Questions about Peter Anastasiou
Answered from the filings on this page, as of the latest one.
Is Peter Anastasiou buying or selling?
Peter Anastasiou has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Peter Anastasiou's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Peter Anastasiou has 0.
Where does Peter Anastasiou file Form 4?
Peter Anastasiou has filed Form 4 at HRMY (Harmony Biosciences Holdings, Inc.) as CHIEF OPERATING OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.